Premium
Social media and pharmacovigilance: A review of the opportunities and challenges
Author(s) -
Sloane Richard,
Osanlou Orod,
Lewis David,
Bollegala Danushka,
Maskell Simon,
Pirmohamed Munir
Publication year - 2015
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.12717
Subject(s) - pharmacovigilance , social media , value (mathematics) , order (exchange) , engineering ethics , medicine , data science , management science , political science , public relations , business , pharmacology , computer science , drug , engineering , finance , machine learning , law
Adverse drug reactions come at a considerable cost on society. Social media are a potentially invaluable reservoir of information for pharmacovigilance, yet their true value remains to be fully understood. In order to realize the benefits social media holds, a number of technical, regulatory and ethical challenges remain to be addressed. We outline these key challenges identifying relevant current research and present possible solutions.